Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001140361-26-016150
Filing Date
2026-04-22
Accepted
2026-04-22 17:00:42
Documents
1
Period of Report
2025-12-31
Effectiveness Date
2026-04-22

Document Format Files

Seq Description Document Type Size
1 ARS ef20071110_ars.pdf ARS 4275367
  Complete submission text file 0001140361-26-016150.txt   5888099
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

EIN.: 452441988 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-38662 | Film No.: 26884579
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)